Join
Live feed
·
INSIDERFilingvia Quantisnow
Mineralys Therapeutics Inc. logo

Director Sblendorio Glenn was granted 6,200 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
MLYS· Mineralys Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MLYS (Mineralys Therapeutics Inc.) and more on Quantisnow.

Director Sblendorio Glenn was granted 6,200 shares (SEC Form 4) | Quantisnow